Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQHLK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,457
Award facts
- Contract value 100% obligated
- $13,457.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,457.06 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml configuration. The order, which is expected to be completed by August 1, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded contract executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. As the prime contractor on this delivery order, the company leverages its position as a major pharmaceutical vendor to supply specialized medications and medical commodities across multiple therapeutic domains. The underlying IDC vehicle enables flexible procurement of brand-name and generic pharmaceutical products, vaccines, and related medical supplies to support military healthcare programs globally, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions in the coming years.
Quick answers
Who was awarded contract SPE2DB25FQHLK?
SPE2DB25FQHLK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FQHLK worth?
The government has obligated $13,457 on SPE2DB25FQHLK.
Is contract SPE2DB25FQHLK an order under another contract?
Yes. SPE2DB25FQHLK is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHLK competed?
The extent of competition for SPE2DB25FQHLK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award